A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults

NCT07035769 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
88
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Debiopharm International SA

Collaborators